LORATADINE
- Product NDC
- 51316-503
- 11-digit product format
- 513160503
- Labeler code
- 51316
- Product ID
- 51316-503_0df114fa-ae43-e77d-e063-6294a90a8c36
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- LORATADINE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- CVS PHARMACY, INC
- Application
- ANDA213294
- Marketing category
- ANDA
- Marketing start
- 2021-08-08
- Substance
- LORATADINE
- Active strength
- 10 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LORATADINE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LORATADINE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7AJO3BO7QN |
| Rxcui | 311373 |
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 51316-503-01 | 2023-02-09 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-02 | 2023-02-09 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-03 | 2023-02-09 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-04 | 2023-02-09 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-05 | 2023-02-09 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-06 | 2023-02-09 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-01 | 2023-01-30 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-02 | 2023-01-30 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-03 | 2023-01-30 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-04 | 2023-01-30 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-05 | 2023-01-30 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
| 51316-503-06 | 2023-01-30 | C162847 | 48780-1 | f386c64a-288c-0266-e053-dadaa90a7c1a | Loratidine Orally Disintegrating Tablets, USP |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51316-503-01 | LORATADINE | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | | 8 |
| 51316-503-01 | LORATADINE | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | | 8 |
| 51316-503-02 | LORATADINE | 20 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 20 | | 8 |
| 51316-503-02 | LORATADINE | 2 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 2 | | 8 |
| 51316-503-03 | LORATADINE | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | | 8 |
| 51316-503-03 | LORATADINE | 30 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 30 | | 8 |
| 51316-503-04 | LORATADINE | 40 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 40 | | 8 |
| 51316-503-04 | LORATADINE | 4 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 4 | | 8 |
| 51316-503-05 | LORATADINE | 50 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 50 | | 8 |
| 51316-503-05 | LORATADINE | 5 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 5 | | 8 |
| 51316-503-06 | LORATADINE | 6 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 6 | | 8 |
| 51316-503-06 | LORATADINE | 60 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 60 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51316-503 | LORATADINE TABLET, ORALLY DISINTEGRATING [CVS PHARMACY, INC] | 8 | Current NDC, Legacy NDC, 12 package rows | 20240102_7ed2aec0-4da7-4edc-9998-b96c67c82738.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51316-503-01 | 51316050301 | 1 BLISTER PACK in 1 CARTON (51316-503-01) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 1 blister pack | 2021-08-08 | 0000-00-00 | No | No | Current |
| 51316-503-02 | 51316050302 | 2 BLISTER PACK in 1 CARTON (51316-503-02) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 2 blister pack | 2021-08-08 | 0000-00-00 | No | No | Current |
| 51316-503-03 | 51316050303 | 3 BLISTER PACK in 1 CARTON (51316-503-03) / 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 3 blister pack | 2021-08-08 | 0000-00-00 | No | No | Current |
| 51316-503-04 | 51316050304 | 4 BLISTER PACK in 1 CARTON (51316-503-04) / 40 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 4 blister pack | 2021-08-08 | 0000-00-00 | No | No | Current |
| 51316-503-05 | 51316050305 | 5 BLISTER PACK in 1 CARTON (51316-503-05) / 50 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 5 blister pack | 2021-08-08 | 0000-00-00 | No | No | Current |
| 51316-503-06 | 51316050306 | 6 BLISTER PACK in 1 CARTON (51316-503-06) / 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 6 blister pack | 2021-08-08 | 0000-00-00 | No | No | Current |